You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Piroxicam - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for piroxicam and what is the scope of freedom to operate?

Piroxicam is the generic ingredient in two branded drugs marketed by Pfizer, Breckenridge, Cycle, Egis, Flamingo Pharms, Hikma, Ivax Sub Teva Pharms, Micro Labs, Mylan, Norvium Bioscience, Nostrum Labs Inc, SCS, Strides Pharma, Sun Pharm Industries, Teva, Teva Pharms, Unichem, Watson Labs, and Zydus Lifesciences, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for piroxicam. Thirteen suppliers are listed for this compound.

Drug Prices for piroxicam

See drug prices for piroxicam

Drug Sales Revenue Trends for piroxicam

See drug sales revenues for piroxicam

Recent Clinical Trials for piroxicam

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of MonastirPhase 2
Mansoura UniversityPhase 2
Farjad ZafarPhase 4

See all piroxicam clinical trials

Pharmacology for piroxicam
Medical Subject Heading (MeSH) Categories for piroxicam

US Patents and Regulatory Information for piroxicam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma PIROXICAM piroxicam CAPSULE;ORAL 209256-001 Aug 11, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Unichem PIROXICAM piroxicam CAPSULE;ORAL 208340-002 Apr 13, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Industries PIROXICAM piroxicam CAPSULE;ORAL 073536-002 Jan 23, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma PIROXICAM piroxicam CAPSULE;ORAL 210347-002 Jan 26, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for piroxicam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-003 Apr 6, 1982 ⤷  Sign Up ⤷  Sign Up
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-003 Apr 6, 1982 ⤷  Sign Up ⤷  Sign Up
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 ⤷  Sign Up ⤷  Sign Up
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.